Triana Biomedicines specializes in the discovery and development of molecular glue therapeutics, utilizing a target-first approach and rational discovery platform. The company focuses on the degradation of significant cancer targets, aiming to revolutionize treatments in the Biotechnology and Pharmaceuticals sectors.
TRIANA Biomedicines belongs to the Biotechnology, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of TRIANA Biomedicines?
TRIANA Biomedicines specializes in Molecular glue therapeutics, Target-first discovery platform, Protein degradation mechanisms, Undruggable cancer targets, Biopharmaceutical innovations.
What products and services is TRIANA Biomedicines likely to offer?
TRIANA Biomedicines offers Molecular Glue Therapeutics, Targeted Protein Degradation, Cancer Treatments, Biopharmaceutical Development, Rational Drug Discovery.
Who are the competitors of TRIANA Biomedicines?
Competitors of TRIANA Biomedicines are Amgen, Ancestry, Molecular Partners, Arvinas, Kymera Therapeutics, Zymeworks.
What does TRIANA Biomedicines do?
Triana Biomedicines specializes in the discovery and development of molecular glue therapeutics, utilizing a target-first approach and rational discovery platform. The company focuses on the degradation of significant cancer targets, aiming to revolutionize treatments in the Biotechnology and Pharmaceuticals sectors.
What are the social media links of TRIANA Biomedicines?
Social media links of TRIANA Biomedicines areTwitterLinkedIn